Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Akerna stock | $4.38

Learn how to easily invest in Akerna stock.

Akerna Corp
NASDAQ: KERN - USD
HEALTH INFORMATION SERVICES
$3.62
-$0.07 (-1.90%)

Akerna Corp is a health information services business based in the US. Akerna shares (KERN) are listed on the NASDAQ and all prices are listed in US Dollars. Akerna employs 144 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in Akerna

  1. Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – KERN – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Akerna stock price (NASDAQ: KERN)

Use our graph to track the performance of KERN stocks over time.

Akerna shares at a glance

Information last updated 2021-07-23.
Latest market close$4.38
52-week range$2.28 - $10.44
50-day moving average $4.12
200-day moving average $4.91
Wall St. target price$10.50
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-2.04

Buy Akerna shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
Sofi Invest
Stocks, ETFs, Cryptocurrency
N/A
0%
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
Webull
Stocks, Options, ETFs
$0
0%
Get one free stock valued between $3.00 and $300 when you open an account, one more with a deposit
Open an account
Margin financing rates start at 3.99%. No monthly subscription fees for margin.
Public
Stocks, ETFs
N/A
$0 per month
Download and sign up with Public.com; approved accounts receive a free stock slice worth up to $70, selected from 9 popular stocks.
Open an account
Commission-free trading in stocks and ETFs with a social networking twist.
J.P. Morgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract
0%
N/A
INVESTMENT AND INSURANCE PRODUCTS ARE: NOT A DEPOSIT • NOT FDIC INSURED • NO BANK GUARANTEE • MAY LOSE VALUE
Robinhood
Stocks, Options, ETFs
$0
0%
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Moomoo
Stocks, Options, ETFs
$0
$0 per year
N/A
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Akerna stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Akerna price performance over time

Historical closes compared with the close of $4.38 from 2021-05-28

1 week (2021-07-19) N/A
1 month (2021-06-30) 8.68%
3 months (2021-04-30) 3.79%
6 months (2021-01-26) N/A
1 year (2020-07-26) N/A
2 years (2019-07-26) N/A
3 years (2018-07-26) N/A
5 years (2016-07-26) N/A

Akerna financials

Revenue TTM $16.6 million
Gross profit TTM $9.4 million
Return on assets TTM -25.75%
Return on equity TTM -70.95%
Profit margin -216.15%
Book value $2.05
Market capitalisation $91.8 million

TTM: trailing 12 months

Shorting Akerna shares

There are currently 2.5 million Akerna shares held short by investors – that's known as Akerna's "short interest". This figure is 18.7% down from 3.1 million last month.

There are a few different ways that this level of interest in shorting Akerna shares can be evaluated.

Akerna's "short interest ratio" (SIR)

Akerna's "short interest ratio" (SIR) is the quantity of Akerna shares currently shorted divided by the average quantity of Akerna shares traded daily (recently around 1.5 million). Akerna's SIR currently stands at 1.65. In other words for every 100,000 Akerna shares traded daily on the market, roughly 1650 shares are currently held short.

However Akerna's short interest can also be evaluated against the total number of Akerna shares, or, against the total number of tradable Akerna shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Akerna's short interest could be expressed as 0.1% of the outstanding shares (for every 100,000 Akerna shares in existence, roughly 100 shares are currently held short) or 0.1358% of the tradable shares (for every 100,000 tradable Akerna shares, roughly 136 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Akerna.

Find out more about how you can short Akerna stock.

Akerna share dividends

We're not expecting Akerna to pay a dividend over the next 12 months.

Akerna share price volatility

Over the last 12 months, Akerna's shares have ranged in value from as little as $2.28 up to $10.438. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Akerna's is 3.1047. This would suggest that Akerna's shares are significantly more volatile than the average for this exchange and represent a higher risk.

Akerna overview

Akerna Corp. operates as a technology company. The company offers MJ Platform, an enterprise resource planning system to the cannabis industry; and Leaf Data Systems, a tracking system designed for government agencies. It also provides consulting services to cannabis industry; business intelligence, an infrastructure as a service tool, which delivers supply chain analytics for the cannabis, hemp, and CBD industries; and Last Call Analytics, a subscription analytics tool for alcohol brands to analyze their retail sales analytics. In addition, the company operates seed-to-sale platform that allows cultivators to track and report various stage of their cannabis growing operations, production, and sales processes. Further, it offers cannabis cultivation management and software to manage and optimize operational workflow in business analytics; and cannabis tracking technology that provides seed-to-sale-to-self data. Akerna Corp.

Frequently asked questions

What percentage of Akerna is owned by insiders or institutions?
Currently 21.285% of Akerna shares are held by insiders and 22.298% by institutions.
How many people work for Akerna?
Latest data suggests 144 work at Akerna.
When does the fiscal year end for Akerna?
Akerna's fiscal year ends in June.
Where is Akerna based?
Akerna's address is: 1630 Welton Street, Denver, CO, United States, 80202
What is Akerna's ISIN number?
Akerna's international securities identification number is: US00973W1027
What is Akerna's CUSIP number?
Akerna's Committee on Uniform Securities Identification Procedures number is: 00973W102

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site